Chronic inflammatory demyelinating polyneuropathy: Difference between revisions

Line 5: Line 5:


==Clinical Features==
==Clinical Features==
*Symmetrical proximal and distal muscle weakness that is progressive for more than two months
*Symmetrical proximal and distal muscle weakness that is progressive for GREATER than two months
*Impaired sensation
*Impaired sensation
*Areflexia
*Areflexia

Revision as of 17:43, 12 September 2020

Background

  • Prevalence of 1 to 2 per 100,000 adults
  • Acute variant is Guillain-Barre syndrome
    • GBS is self limited whereas CIPD is progressive for more than two months

Clinical Features

  • Symmetrical proximal and distal muscle weakness that is progressive for GREATER than two months
  • Impaired sensation
  • Areflexia
  • Elevated CSF protein
  • EMG studies consistent with demyelination
  • Nerve demyelination on nerve biopsies
  • Can be relapsing or chronic and progressive

Differential Diagnosis

Weakness

Evaluation

Workup

Diagnosis

Management

Disposition

See Also

External Links

References